Nicotinamide mononucleotide
3 papers1 finding
- Animals2
- Cells1
Interventions
1FK866
downin mammals cells1
1 study
FK866
downin mammals cells1
FK866 prevents nicotinamide mononucleotide in mammals cells.
“both the NAMPT inhibitor FK866 and the axon protective protein Wld(S) prevent this rise.”
Cellsprior to degeneration
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
Cell death and differentiation17 Oct 2014
Funding
1 grant since 2023Veterans Affairs
Latest
25 in 12 monthsClinical Interventions in Aging
Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review
ReviewMultimorbidity
Journal of Aging Research
β-Nicotinamide Mononucleotide Inhibits Cellular Senescence in Mouse C2C12 Skeletal Muscle Cells
Experiments in mouse cellsNicotinamide mononucleotide
Research Square
Long-term NMN treatment increases lifespan and healthspan in mice in a sex dependent manner
Preprint: experiments in miceNicotinamide mononucleotide
Science Advances
Endothelial C/EBPβ/AEP pathway drives vascular deterioration and systemic aging
Experiments in miceMechanisms
Pharmacological Research
NMN mitigates LPS-induced liver injury by inhibiting ferroptosis via suppression of the cGAS-STING-ACSL4 axis
Experiments in miceNicotinamide mononucleotide
Experimental Gerontology
Bazi Bushen attenuates musculoskeletal degeneration in Ercc1+/- mice
Experiments in 6 miceInterventions
Drug Design, Development and Therapy
A Staged Translational Framework for Evaluating Oral Glutamatergic and Senescence-Modulating Strategies in Treatment-Resistant Depression
CommentaryInterventions